Pirfenidone Information Webcast

Dr. Talmadge King: A very highly regarded doctor with an expertise in pulmonary fibrosis. I have met him, spoken with him and was entranced by a lecture of his years ago. If you have IPF, this would be worth your while. Patients, caregivers and family members often contact the Coalition for Pulmonary Fibrosis (CPF) with questions about recently FDA approved drugs for Idiopathic Pulmonary Fibrosis (IPF).  We want to inform you about an upcoming webcast about Esbriet (pirfenidone) that will be held on February 24th and will be hosted by renowned PF expert, Dr. Talmadge King.  This webcast will help answer your questions so we encourage you to make your reservation now to attend this online event. Please see full details below. Sincerely,  Mishka Michon, CEO Coalition for Pulmonary Fibrosis Learn more about Esbriet® (pirfenidone), the recently FDA-approved therapy for idiopathic pulmonary fibrosis (IPF) Sign up for an educational webcast About the program conducted by Genentech: During the webcast, you will learn the potential benefits and risks of Esbriet, results from Esbriet studies in IPF, and the support available to guide you through treatment.  The Esbriet program will be hosted by Dr. Talmadge King, Chair of the Department of Medicine at the University of California, San Francisco. Dr. King is an expert in the care of IPF patients. The webcasts will take place on February 24, 2015. Choose the time that fits your schedule. You will need Internet and phone access to attend the program. Register for the Esbriet Educational Webcasts on February 24, 2015 11:00 am–12:00 pm EST or 7:00–8:00 pm EST To register for one of these programs, please click on the link below or enter the following address on your Internet browser: esbrietpatientwebcast.com. You may also call 855-888-4866 between the hours of 9:00 am and 5:00 pm EST to register. About Esbriet Esbriet is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF). Indication and Select Important Safety Information What should I tell my doctor before taking Esbriet? Before you take Esbriet, tell your doctor if you: have liver problems have kidney problems are a smoker have any other medical conditions are pregnant or plan to become pregnant. It is not known if Esbriet will harm your unborn baby are breastfeeding or plan to breastfeed. It is not known if Esbriet passes into your breast milk. You and your doctor should decide if you will take Esbriet or breastfeed. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What should I avoid while taking Esbriet? Avoid sunlight. Esbriet can make your skin sensitive to the sun and the light from sunlamps and tanning beds. You could get a severe sunburn. Use sunscreen (SPF 50) and wear a hat and clothes that cover your skin if you have to be in sunlight. Talk to your doctor if you get sunburn. Avoid smoking. Smoking may affect how well Esbriet works. What are the possible side effects of Esbriet? Esbriet may cause serious side effects, including: liver problems. Call your doctor right away if you have unexplained symptoms such as yellowing of your skin or the white part of your eyes (jaundice), dark or brown (tea-colored) urine, pain on the upper right side of your stomach area (abdomen), bleeding or bruising more easily than normal, feeling tired. Your doctor will do blood tests to check how your liver is working during your treatment with Esbriet. sensitivity to sunlight (photosensitivity) and rash. See “What should I avoid while taking Esbriet?” stomach problems. Esbriet may cause stomach problems such as nausea, vomiting, diarrhea, indigestion, heartburn, and stomach pain. Tell your doctor right away if your stomach problems get worse or do not go away. Your doctor may need to change your dose of Esbriet. The most common side effects of Esbriet include feeling tired, headache, dizziness, and decreased or loss of appetite. These are not all the possible side effects of Esbriet. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-486-6411. Please see the full Prescribing Information, including the Patient Information for Esbriet here. For more information about Esbriet, please visit www.esbriet.com or call 1-888-486-6411. This information is intended for US residents only. The information provided is not meant to replace your doctor’s advice. If you have questions about IPF or your healthcare, discuss your concerns with your doctor. This e-mail is powered by CPF. © 2015 Genentech USA, Inc. All rights reserved. PRC-3317 01/15       Coalition for Pulmonary Fibrosis 10866 W. Washington Blvd. #343 Culver City, CA 90232 (888) 222-8541 info@coalitionforpf.org